Saturday 17 October 2026 Export ALKS’s income statement to Excel — free account

Alkermes plc

ALKS Healthcare Drug Manufacturers Specialty & Generic

Alkermes plc’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 5.25% from fiscal 2024. In the quarter to June 2026, revenue grew 27.0%, EPS fell 99.4% and free cash flow grew 1.13%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

41.22 1.12 +2.79%

Follow ALKS

Alert me

Market cap: $6.7B
P/E: 102×
Fwd P/E: −108×
Dividend yield: —
F-score: 7/9
Altman Z: 5.33
Beneish M: −3.29
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	130.02	38.02	19.03	14.49	+8 more quarters Free account
P/S ratio Full definition →	5.25	3.76	3.12	3.26
P/FCF ratio Full definition →	39.30	26.57	9.57	10.09
P/Operating CF Full definition →	60.28	(35.46)	27.10	48.71
P/B ratio Full definition →	4.84	3.36	2.53	2.86
Price to Tangible BV Full definition →	0.00	0.00	2.66	3.00
EV/Sales Full definition →	5.76	4.40	2.42	2.71
EV/EBITDA Full definition →	43.12	28.20	12.73	10.63
EV/Operating CF Full definition →	38.21	26.84	6.87	7.63
EV/FCF Full definition →	43.10	31.08	7.43	8.41
Quick Ratio Full definition →	1.68	1.53	3.04	3.09
Current Ratio Full definition →	2.30	2.27	3.55	3.67
Net Debt/EBITDA Full definition →	10.63	(61.92)	(21.30)	(11.44)
Debt/Assets Full definition →	34.22%	35.47%	0.00%	0.00%
Debt/Equity Full definition →	0.83	0.86	0.00	0.00
Asset Turnover Full definition →	0.50	0.49	0.65	0.68
Operating CF/Net income Full definition →	289.79	2.49	3.45	1.23
Capex/Depreciation Full definition →	(0.13)	(0.13)	0.28	(2.14)
Interest Coverage Full definition →	0.71	(2.31)	—	—
Research and Development Expense of Revenue Full definition →	22.77%	26.30%	24.19%	20.74%
Selling, General and Administrative Expense of Revenue Full definition →	43.88%	67.34%	48.68%	43.58%
Intangible Assets out of Total Assets Full definition →	0.54	0.56	0.03	0.04
Share Based Compensation of Revenue Full definition →	6.28%	9.25%	6.83%	6.26%
Graham Net Nets Full definition →	(0.12)	(0.20)	0.27	0.23
Graham Number Full definition →	9.91	14.85	19.11	22.11
Earnings Yield Full definition →	0.77%	2.63%	5.25%	6.90%
Free Cash Flow Yield Full definition →	2.54%	3.76%	10.45%	9.91%
Revenue per Share Full definition →	2.97	2.36	2.33	2.39
Operating CF per Share Full definition →	0.87	(1.00)	1.03	0.62
Capex per Share Full definition →	(0.05)	(0.02)	0.01	(0.10)
Free Cash Flow per Share Full definition →	0.82	(1.02)	1.04	0.51
Cash per Share Full definition →	3.93	3.08	8.01	6.73
Shareholders Equity per Share Full definition →	10.83	10.54	11.05	10.50
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	10.83	10.54	11.05	10.50
Free Cash Flow Full definition →	137.04	(169.82)	171.14	84.36
Working Capital Full definition →	860.82	759.15	1,385.72	1,267.30
Capital Expenditures Full definition →	(8.15)	(4.08)	1.07	(17.31)
Net Current Asset Value Full definition →	(1,061.67)	(1,147.90)	1,261.46	1,145.58
EV/EBIT Full definition →	81.86	35.83	14.09	11.52
Capex to Sales Full definition →	0.02	0.01	0.00	0.04
Price to Operating Income Full definition →	74.64	30.63	18.15	13.81
Other line items
Average Receivables Full definition →	405.69	363.17	359.28	360.80
Average Payables Full definition →	289.11	239.31	237.45	187.59
Average Inventory Full definition →	245.44	260.07	189.76	191.04
Average Assets Full definition →	3,322.97	3,170.03	2,271.28	2,242.40
Average Common Equity Full definition →	1,716.57	1,631.56	1,642.14	1,512.77

Fold the line items

Columns are period end dates

Stockrow Weekly